Forum Replies Created
-
AuthorPosts
-
See this for links to the latest about this combo: http://hepatitiscnewdrugresearch.com/grazoprevirelbasvir.html
It is only phase 2 stuff, so not at scale.
Grazoprevir (an NS3/4A protease inhibitor) and elbasvir (an NS5A inhibitor) and it is being used with Ribavirin.
It would be comparable to using Simeprevir (NS3/4A) and Ledipasvir/Daclatasvir (NS5A).
It is missing the secret sauce of Sofosbuvir’s pan genotypic log 4.5 kill rate.
Merck show real decency with their $4.50 Gardasil vaccine price to the 3rd world compared to their $130 1st world price which of course looks nothing like Gilead’s pricing structure. It would be great if they could get 95% + cure rates (preferably without Riba) but it’s still an open question because the trials are still small.
YMMV
Most drugs are metabolised by the liver. Even something as routine as Paracetamol/Acetaminophen can be liver toxic – while 2 x 500 mg four times a day is safe, if you take all 20 at once there is a good chance you get liver failure.
So as a rule of thumb many medications are liver toxic at high doses – in effect the liver can not process them fast enough and toxic products build up. A number of promising drugs across many areas have failed in Phase 2/3 trials when patient have got liver failure from them.
YMMV
This article discusses “Drug Eruption Medications” which along with “Fixed Drug Eruption” is secret doctor code for a rash caused by drugs:
http://emedicine.medscape.com/article/1049474-medication
A Google for the search term “Fixed drug eruption treatment” should turn up many more articles.
YMMV
Daclatasvir is a good medication but please be aware of interactions with other medications. You can check for them here: http://www.hep-druginteractions.org/checker
YMMV
RVR is to prove the medication APIs in the exact formulation provided “works” in terms of generating a Rapid Virological Response.
With Twinvir I already know this but with the Sof/Dac product, we expect it to work, but there are no comparators.
Both trial meds need this sanity check.
It would be ever so slightly embarrassing to give a lot of patient-paid medication to patients and find it failed dismally…
YMMV
The world exists as we find it. I dream of better, work with now, and aim for the future…
YMMV
I am a newbie, have been reading and reading all the info. Have had Hep C at least 30yrs. GT1a, 15 million VL, 139 and 229 LFT. getting a fibro scan this week. No prior TX. Losing weight and feeling a bit scared. I doubt Medicare will come through for me and considering a trip to Hobart. I love being able to hear your stories and have hope thanks to all of you.
YMMV
Hi all, can someone in the US take part in the trials?
YMMV
Yes, there are patients at SVR4, SVR12 and one I know of at SVR24 (who sourced research APIs very early on)
I have over 100 patients on generics and all but 3 were VL = 0 at 4 weeks. One was VL = 0 at EOT and the other 2 are pending 6 week load testing (one with VL 47 @ 3.5/52, the other < 15) Bioequivalence as in pharmacokinetic AUC testing is a cheap hack to avoid doing actual trials when introducing generics. The actual clinical results on these generics are in line with expectations.
YMMV
You are welcome. As a doctor I would have no difficulty in supporting a decision to treat.
If it was my son I would treat them if they wanted to.
If, in the worst case, it went badly I would find solace in knowing we tried.
While we know these drugs have risks they are far safer than Interferon/Ribavirin and they have been used. In “UpToDate”
http://www.uptodate.com/contents/hepatitis-c-virus-infection-in-children
We can read that PEG Interferon/Ribavirin is approved for use in children.
To me that’s like saying amputation is approved for the treatment of gangrene in children but I can’t give you antibiotics because they are too new and only approved in adults.
Personally I would take a punt on the antibiotics and leave the amputation to the annals of history….
YMMV
Bangladesh will be the first country to be able to prove the clinical quality of their generics in the only way possible, via a 3000 person clinical trial the tracks the outcome for taking that specific formulation.
YMMV
You won’t find an official answer, and the trials in children are phase 2 and not scheduled for completion until August 2017.
https://clinicaltrials.gov/ct2/show/NCT02249182
So let’s resort to the logic of first principles.
Children are different in three primary ways (physiologically)
- They are growing both physically and mentally
- They may not have all the metabolic pathways for drug breakdown seen in adults
- They are a different weight
He’s old enough that most of his bits are fully formed but some – cartilage in bones allowing them to grow, and his brain are not – it’s possible these medications could do stuff here – ?
You can observe that for many common medications there are < 12 yo doses and then Adult doses - tick If your son is full sized then we need not have concerns that the tablet size is too big for his body - tick So if you weigh up the risks of treatment they are real, and to a degree unknown. Then you look at the impact of Hep C and the risks of having it - they are real, substantial and well known. To my logic the risk of treatment are small, the risks of not treatment are large, so the risk:benefit stacks up on the treatment side. He's around the age of Gillick competence which is where the child is deemed capable of consent (usual situation an underage girl seeking either contraception or a termination). On that basis if he wants to do it, and you are assessing a significant impact treatment is not unreasonable. There is nothing magical that suddenly happens on a child's 18th birthday that says yesterday treatment was dangerous, but today it's safe. It is an arbitrary line in the sand and an adult sized 15 year old should tolerate an adult dose of medication fine and have a risk profile similar to an adult. I would certainly be thinking along your lines if faced with the same dilemma.
YMMV
Don’t panic!
An API is what is known as the “Active Pharmaceutical Ingredient” ie Sofosbuvir or Ledipasvir.
If you take Gilead as an example the APIs for Harvoni are made in Jordan.
This chemical powder is then shipped to Ireland where the two parts are mixed with glue, lactose (milk sugar), fibre, disintegrant, sand, wax and pressed into tablets.
The extra bits are called excipients and can be used to control rate of release but in the case of Harvoni it’s a fast release instant dissolution.
Harvoni Excipients:
- Copovidone (glue)
- Lactose monohydrate (sugar)
- Microcrystalline cellulose (fibre)
- Croscarmellose sodium (disintegrant)
- Colloidal anhydrous silica (sand)
- Magnesium stearate (wax)
What you have is the APIs mixed with Microcrystaline cellulose in a capsule that, like Harvoni releases the API rapidly. The other parts of the tablet are only used to make the table stick together, and then dissolve in your stomach. It’s cheaper to make a tablet than a capsule which is why they are commonly used.
There are now hundreds of people now have taken Sofosbuvir/Ledipasvir in this form and are at viral load zero.
The APIs in both Twinvir and your medication came from China (different large scale factories). They are chemically identical the the APIs in Harvoni and you can read the testing reports about that here: Testing Provisions Patient Safety.
YMMV
Here’s a video about it:
[video width=425 height=344 type=youtube]vCcpES8O6P0[/video]
YMMV
Thank you for posting this. I have updated the side effects page to link back here and added some additional data to it around the ADRs and mortality risk.
http://fixhepc.com/getting-treated/how-to-do-it/treatment-side-effects.html
One of the problems with this demographic group is age.
At the age of 65 you have over a 2% per year risk of dying, or 0.5% per 12 weeks.
What this means is that if I started a hair brushing trial, and brushed the hair of people in this age group every day for 12 week, and did it to 200 people, one would probably die (statistically) during this period.
Now intuitively we know it was probably not the hair brush that killed them, but they still died while having their hair brushed daily.
Sadly some people will die taking these medications, but when you look at the big picture 10,000 times as many people died last year (500,000) because they did not take these medications, than those who may have died because they did take them (< 50).
YMMV
-
AuthorPosts